Glucometric parameter changes in patients with type 2 diabetes during ramadan fasting: A prospective comparative real-world study

被引:1
|
作者
Al Hayek, Ayman [1 ]
Al Zahrani, Wael M. [1 ]
Al Dawish, Mohamed Abdulaziz [1 ]
机构
[1] Prince Sultan Mil Med City, Diabet Treatment Ctr, Dept Endocrinol & Diabet, Riyadh, Saudi Arabia
来源
METABOLISM OPEN | 2024年 / 23卷
关键词
Type 2 diabetes mellitus; Ramadan fasting; Glucose monitoring; Self-care management; GLYCEMIC CONTROL; GLUCOSE LEVEL; MELLITUS; CARE; ASSOCIATION; PROFILE; IMPACT;
D O I
10.1016/j.metop.2024.100304
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This study assessed glucometric changes in Type 2 diabetes mellitus (T2DM) patients before, during, and after Ramadan fasting using an intermittently scanned continuous glucose monitoring system (isCGMS). Methods: This prospective comparative study included T2DM patients aged 30-70 years who were receiving nonintensive insulin in Riyadh, Saudi Arabia. In addition to the baseline characteristics, glycated hemoglobin (HbA1c) and ambulatory glucose profile (AGP)-derived metric data were collected at three specific points: pre-, during-, and post-Ramadan. Self-care activities during Ramadan were evaluated using the Diabetes SelfManagement Questionnaire (DSMQ). Results: Overall, a total of 93 T2DM patients were enrolled in the study. Their mean age +/- SD age was 47.9 +/- 7.5 years, and 51.6 % of them were males. Compared with pre- and post-Ramadan, there was a significant decrease in HbA1c (p < 0.001 for both periods), average glucose level (p = 0.001 and p = 0.026, respectively), glucose variability (p = 0.043 and p = 0.005, respectively), and % time above the range of 181-250 mg/dL (p < 0.001 for both periods), as well as a significant increase in % time in target (70-180 mg/dL) during Ramadan (p < 0.001 for both periods). However, the % time below 54 mg/dL was slightly greater during Ramadan than both pre- and post-Ramadan (p <0.001 and p = 0.002, respectively). Furthermore, 32.3 % reported inadequate selfcare behaviors during Ramadan. Conclusions: Ramadan fasting could improve glucose levels in T2DM patients who were not on intensive insulin, with a relatively low incidence of hypoglycemia.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study
    Hassanein, Mohamed
    Malek, Rachid
    Shaltout, Inass
    Sahay, Rakesh Kumar
    Buyukbese, Mehmet Akif
    Djaballah, Khier
    Pilorget, Valerie
    Coudert, Mathieu
    Al Sifri, Saud
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (02)
  • [22] Tolerability of canagliflozin in patients with type 2 diabetes fasting during Ramadan: results of the Canagliflozin in RAmadan Tolerance Observational Study (CRATOS)
    Hasanein, M.
    Echtay, A.
    Hassoun, A.
    Alarouj, M.
    Afandi, B.
    Poladian, R.
    Bennakhi, A.
    Nazar, M.
    Bergmans, P.
    Keim, S.
    Hamilton, G.
    Azar, S. T.
    DIABETOLOGIA, 2017, 60 : S405 - S405
  • [23] The Impact of Fasting during Ramadan on the Glycemic Control of Patients with Type 2 Diabetes Mellitus
    Sahin, S. B.
    Ayaz, T.
    Ozyurt, N.
    Ilkkilic, K.
    Kirvar, A.
    Sezgin, H.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2013, 121 (09) : 531 - 534
  • [24] Fasting experience of patients with Type 2 diabetes mellitus on insulin therapy during Ramadan: VISION Ramadan substudy
    Jabbar, Abdul
    Mohamed, Wan Mohd Izani Wan
    Spaepen, Erik
    Reed, Victoria
    Tayeb, Khaled
    Khalil, Samir H. Assaad
    Treuer, Tamas
    Bhattacharya, Indranil
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 151 : 285 - 289
  • [25] Treatment Options for Patients with Type 2 Diabetes Mellitus during the Fasting Month of Ramadan
    Loh, Huai Heng
    Kamaruddin, Nor Azmi
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2020, 49 (07) : 468 - 476
  • [26] Attitudes and habits of patients with type 1 diabetes during fasting Ramadan
    Alamoudi, Reem
    Alsubaiee, Maram
    Alqarni, Ali
    Aljaser, Saleh
    Saleh, Yousef
    Salam, Abdul
    Eledrisi, Mohsen
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2018, 14 : 1 - 4
  • [27] Effectiveness of V-Go® for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational Study
    Grunberger, George
    Rosenfeld, Cheryl R.
    Bode, Bruce W.
    Abbott, Scott D.
    Nikkel, Carla
    Shi, Leon
    Strange, Poul
    DRUGS-REAL WORLD OUTCOMES, 2020, 7 (01) : 31 - 40
  • [28] Effectiveness of V-Go® for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational Study
    George Grunberger
    Cheryl R. Rosenfeld
    Bruce W. Bode
    Scott D. Abbott
    Carla Nikkel
    Leon Shi
    Poul Strange
    Drugs - Real World Outcomes, 2020, 7 : 31 - 40
  • [29] Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS)
    Hassanein, Mohamed
    Echtay, Akram
    Hassoun, Ahmed
    Alarouj, Monira
    Afandi, Bachar
    Poladian, Raffi
    Bennakhi, Abdullah
    Nazar, Maciej
    Bergmans, Paul
    Keim, Sofia
    Hamilton, Gill
    Azar, Sami T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (10)
  • [30] Interventions for people with type 2 diabetes mellitus fasting during Ramadan
    Lee, Shaun Wen Huey
    Chen, Won Sun
    Sellappans, Renukha
    Sharif, Shakirah Binti Md.
    Metzendorf, Maria-Inti
    Lai, Nai Ming
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (07):